INTRODUCTION
In early mammalian development, primitive ectoderm cells forming the inner cell mass of blastocysts are pluripotent and subsequently give rise to all cells of the body. The pluripotent state can be maintained in blastocyst-derived embryonic stem (ES) cells ex vivo and can be reprogrammed in somatic cells, generating induced pluripotent stem (iPS) cells (Orkin and Hochedlinger, 2011) . In pluripotent cells, the expression of differentiation-related genes is suppressed despite a globally open chromatin that allows for access to genes required for rapid self-renewal and for the subsequent initiation of differentiation programs (Orkin and Hochedlinger, 2011) . The stem cell program is orchestrated by three core transcription factors, Oct4, Nanog, and Sox2. These factors cooperate with a network of molecules that includes other transcription factors, noncoding RNAs, transcriptional coactivators, corepressors, and chromatin regulators (Young, 2011) . However, despite important progress, the molecular mechanisms underlying early development and pluripotency remain incompletely understood.
Gene regulation in pluripotent stem cells is dependent on the activity of several multiprotein complexes that influence transcription by modifying chromatin, including Polycomb Repressive Complexes (PRCs) (Simon and Kingston, 2009 ). PRCs regulate patterning by repressing Hox genes in Drosophila development and also control developmental genes in mammalian ES cells (Simon and Kingston, 2009) . Two types of mammalian Polycomb complexes are known, PRC1 and PCR2. The composition of these complexes varies in different contexts, and, recently, distinct PRC1-family complexes have been defined (Gao et al., 2012) . Germline disruption of components of PRC2 is invariably associated with early embryonic lethality, while Ring1b and Rybp are the only PRC1 components with essential early embryonic roles (Table S1 , available online). PRC1 and PRC2 act coordinately in ES cells, and disruption of components of either complex leads to derepression of lineage-specific genes. The PRC2 component EZH2 mediates trimethylation of histone 3 lysine 27 (H3K27me3). H3K27me3 serves as a docking site for a PRC1 chromodomain protein (Drosophila: polycomb; mammalian CBX2/4/6/7/8) at a large proportion of PRC2 target genes. Ring1b, the catalytic PRC1 subunit, then mediates mono-ubiquitination of histone 2A lysine 119 (H2AK119ub1). It is unresolved how these modifications mediate gene repression, and Ring1b has the potential to repress genes and compact chromatin independent of histone ubiquitination (Simon and Kingston, 2009 ). Both mammalian PRCs can also act independently. Repression of some genes is maintained by the remaining complex after selective disruption of either PRC1 or PRC2 (Leeb et al., 2010) , and PRC1 can be recruited to PRC2 target genes in PRC2's absence (Tavares et al., 2012) . L3mbtl2 has been implicated as a component of the repressive E2F6-complex that contains Polycomb group proteins also linked to PRC1 in several independent studies (Ogawa et al., 2002; Sá nchez et al., 2007; Tahiliani et al., 2007; Trojer et al., 2011) .
Malignant Brain Tumor (MBT) domains participate in the organization of DNA in chromatin by binding histones and compacting chromatin (Trojer et al., 2007) . Characteristically, they display a strong preference for binding to mono-and dimethylated lysine residues in histone tails. MBT domains were first recognized in a family of three genes in Drosophila comprised of l(3)mbt, scm, and sfmbt, all of which are essential for development. Scm and sfmbt strongly repress Hox genes in Drosophila and bind Polycomb responsive elements (Klymenko et al., 2006; Wang et al., 2010) . However, neither molecule is a core constituent of Drosophila PRC1 or PRC2 (Klymenko et al., 2006; Wang et al., 2010) . In mammals, the family of MBT domain proteins has expanded to nine members and their functions are less well defined (Qin et al., 2010) . We have previously shown that mice lacking L3mbtl1 are viable (Qin et al., 2010) . Similarly, Scmh1 À/À mice display only mild phenotypes with variable penetrance (Takada et al., 2007) , and disruption of Sfmbt1 in mice is not associated with obvious phenotypes (J.Q., H.H., unpublished data). Mice lacking L3mbtl3 and Mbtd1 die at birth with skeletal defects and compromised hematopoiesis (Arai and Miyazaki, 2005; Honda et al., 2011) . However, none of these knockout models have revealed cell types for which MBT domain proteins are strictly essential, and no requirement in embryonic development has been described. Here we examine the function of L3mbtl2, an ortholog of Drosophila sfmbt also known as h-l(3)mbt-like or m4mbt (Guo et al., 2009) .
RESULTS

L3mbtl2 Is Essential for Mouse Development
L3mbtl2 is widely expressed ( Figure 1A ). We disrupted L3mbtl2 in ES cells and mice by flanking the exons encoding its three C-terminal MBT domains (residues 315-308) with loxP sites and removing them by Cre-mediated recombination ( Figure 1B , Figure S1 ). This strategy probably resulted in a true ''null'' allele because we could not detect mutant mRNA ( Figure 1C ) or mutant protein (Figure 2A ). Mice heterozygous for the disrupted L3mbtl2 allele appeared normal and were fertile. However after intercrossing heterozygotes, no homozygous pups were born ( Figures 1D and 1E ). At embryonic day (E) 6.5, L3mbtl2
À/À embryos were present at the expected frequency, and their Figure S1 ). (C) RT-PCR analysis of mRNA for L3mbtl2 using primers in the 5-prime region (not deleted in the genome) demonstrates that mutant mRNA is nondetectable and likely unstable (see Figure 2A for analysis of protein).
(D and E) Progeny of heterozygous mutant mice bearing germline-excised L3mbtl2.
(D) No homozygous mutants were detected after birth. At macroscopic examination upon dissection at E6.5, L3mbtl2 À/À embryos appeared roughly normal in size (E, left). After E7.5, mutants were growth retarded. At E8.5, mutant embryos were minute (E, right), and at E9.5, only debris was recovered from decidua.
(F) Immunohistological analysis of L3mbtl2 +/+ and L3mbtl2 À/À blastocysts at E3.5 revealed that both form trophectoderm (TE, expressing Cdx2) and inner cell mass (ICM, expressing Nanog).
(G and H) Histologic sections from uteri at E6.5 show wild-type embryos with well-defined cavities segmented by chorion (G, arrow 1) and amnion (G, arrow 2) membranes and mutant embryos with unstructured cores (H, arrow) (for further histology see Figure S2 ).
genotype could not be predicted by inspection ( Figures 1D and  1E ). In contrast, at and after E7.5, mutant embryos showed growth retardation ( Figures 1D and 1E ). Immunohistological analysis of blastocysts at embryonic day (E) 3.5 revealed no differences of trophectoderm (Cdx2 + ) and inner cell mass (Nanog + ) ( Figure 1F ). To investigate later effects of L3mbtl2 loss, we analyzed serial histological sections of whole uteri ( Figures 1G and 1H , Figure S2 ). At E6.5, mutant embryos were surrounded by mural trophectoderm and a normal outer epithelial layer of primitive endoderm ( Figures S2C and S2D) . However, the core of the mutant embryos consisted of an abnormal, unstructured mass of irregular cells (Figure 1H, Figure S2D) . Normal embryos at the egg cylinder stage (E5.5) harbor an inner ectodermal layer surrounding the proamniotic cavity. The latter becomes divided as the chorion and amnion develop ( Figure 1G , Figure S2C ). At E6.5, L3mbtl2 mutants did not . Cyclin E was reduced and its inhibitors p21 and Lats2, increased. The expression levels of cyclin A, p16, and p53 were not altered. Shown is relative mRNA expression (ratio: measured mRNA/ GAPDH mRNA).
(M) Chromatin immunoprecipitation with L3mbtl2-F followed by qPCR revealed enrichment for the promoter regions of p21, but not cyclin E, Lats2 or HPRT (shown are means in % of input; p21 binding was also confirmed by ChIP-seq, Table S4 ).
(B-M) Significance: two-tailed Student's t tests; means were derived from three biologically independent samples; errors are standard deviations (SD). See Figure S3 for analysis of L3mbtl2 À/À MEFs.
show a distinct ectodermal epithelial layer, proamniotic cavity, chorion, or amnion ( Figure 1H , Figure S2D ). While wild-type E8.5 embryos had progressed in establishing the basic body plan as a result of gastrulation, mutant embryos showed little growth or development ( Figure S2E-S2H) . Thus, L3mbtl2 is not required for implantation or formation of trophectoderm, primitive endoderm, and the inner cell mass. However in its absence, the inner cells mass fails to form a normal primitive ectoderm capable of gastrulation. This knockout phenotype bears similarity with those associated with other Polycomb group proteins (Table S1 ).
L3mbtl2
Regulates ES Cell Proliferation, but Is Not Required for Maintenance of ES Cell Identity The embryonic phenotype suggested that L3mbtl2 might be required for the function of pluripotent cells of the inner cell mass, which give rise to ES cells ex vivo. Therefore, we disrupted both alleles of L3mbtl2 in ES cells ( Figure S1E ). This resulted in complete loss of L3mbtl2 protein ( Figure 2A ). Upon loss of L3mbtl2, ES cell colony size was drastically reduced ( Figure 2B ), and we observed a severe proliferation defect ( Figure 2C , doubling time increased from $13 hr to $33 hr). Remarkably, however, lentiviral expression of FLAG-tagged L3mbtl2 entirely restored normal ES cell growth and protein expression (Figures 2A-2C ). Importantly, despite expression of L3mbtl2 in murine embryonic fibroblasts (MEFs, E13.5), its disruption did not alter their growth ( Figure S3 ). Thus, L3mbtl2 selectively regulates proliferation in the context of ES cells. Despite these growth abnormalities, L3mbtl2 À/À ES cells retained characteristics of pluripotent cells. Stat3 phosphorylation in response to LIF was not altered ( Figure 2D ), and L3mbtl2
ES cells expressed Alkaline Phosphatase ( Figure 2E ) as well as the pluripotency factors Oct4, Nanog, and Sox2 at normal levels ( Figure 2F ). The pluripotency marker SSEA1 was expressed by L3mbtl2 À/À ES cells, but its levels were reduced in a proportion of cells ( Figure 2G ). L3mbtl2 À/À ES cells with diminished SSEA1 expression had a significantly reduced capacity to give rise to ES cell colonies, but L3mbtl2 À/À ES cells with high SSEA1 levels gave rise to colonies almost as efficiently as wild-type ES cells ( Figure 2H ). Moreover, we were able to stably maintain L3mbtl2 À/À ES cells in culture for > 36 passages (not shown).
Thus, L3mbtl2 À/À ES cells are subject to a higher propensity for spontaneous differentiation, but unlimited self-renewal is preserved, albeit at a drastically reduced rate. The impaired growth of L3mbtl2 À/À ES cells was not due to increased apoptosis ( Figure 2I ), but correlated with an altered cell cycle profile ( Figure 2J ). This was associated with markedly increased proportions of cells in the G 0/1 phases of the cell cycle and a reduction of cells in S phase. Consistently, expression of cyclin E, which promotes transition from the G1 to the S phase, was reduced (Figures 2K and 2L) and its inhibitors p21 cip1/waf1 and Lats2 were increased (Figures 2K and 2L) . Expression levels of p53, a transcriptional activator of p21 cip1/waf1 , were not altered. Intriguingly, Oct4 loss results in a similar G 1 /S block with p53-independent upregulation of p21 cip1/waf1 (Lee et al., 2010) . Remarkably, ChIP analysis revealed binding of L3mbtl2 to the proximal promoter p21 cip1/waf1 , but not Lats2 or cyclin E ( Figure 2M , confirmed by ChIP-seq, Table S4 ). Thus, p21 cip1/waf1 is a direct transcriptional target of L3mbtl2 in ES cells.
L3mbtl2 Controls Differentiation Programs in ES Cells and Early Development
We utilized EBs as a model system of early development (Figure 3A) . L3mbtl2 À/À ES cells did form EBs, but these were smaller and failed to develop cystic structures ( Figure 3B , day 12). L3mbtl2 À/À EBs expressed markers for definitive ectoderm ( Figure 3C , left, top), mesoderm ( Figure 3C , left, middle), and endoderm ( Figure 3C , bottom) (see Supplemental Experimental Procedures for references), However, the expression of markers for all germ layers was abnormal ( Figure 3C , left). Strikingly, we detected increased expression of Sox17, Gata6, Gata4, and Foxa2 in undifferentiated L3mbtl2 À/À ES cells and throughout EB culture, indicating that L3mbtl2 suppresses endoderm (Figure 3C, bottom) . In normal EB maturation, early populations (mesoendoderm and primitive ectoderm) fade as more mature tissues are formed (Shen et al., 2009) . Accordingly, brachyury (mesoendoderm marker, left middle) and Fgf5 (primitive ectoderm marker, Figure 3C , right, top), as well as Oct4 and Nanog (pluripotent cell markers, Figure 3C , right, top), were highly expressed in wild-type day 7 EBs, but strikingly reduced at day 12. In contrast, these markers persisted abnormally in L3mbtl2 À/À EBs, suggesting that primitive ectoderm and meso-endoderm cells did not efficiently progress in maturation. Finally, we observed increased expression of Eomes, Cdx2, and Hand1 ( Figure 3C , right, bottom, particularly at day 12), suggesting that L3mbtl2 also suppresses the trophectoderm. To assess whether L3mbtl2 À/À ES cells give rise to more differentiated cells, we assayed teratoma formation ( Figures  3D-3K ). Remarkably, growth of L3mbtl2 À/À teratomas was delayed for several weeks ( Figure 3E ). By comparison, teratomas lacking Eed or Ring1b form after a normal interval, even though they were 50% smaller (Leeb et al., 2010 S4C , and S4I-S4L), and areas resembling mature neural tissue (Figure 3G right, and Figures S4B and S4C) . L3mbtl2 À/À teratomas also exhibited trophectoderm differentiation , which is never seen in control teratomas. Together, these data reveal a complex role for L3mbtl2 in early development. It is not essential for the potential to give rise to derivatives of all three germlayers (pluripotency) ( Figure 3C ). However, it is required for suppressing endodermal and trophectodermal genes in ES cells and EBs. Moreover, L3mbtl2 promotes differentiation programs: early cell populations, expressing Oct4, Fgf5, and Brachyury, persist in late-stage L3mbtl2 À/À EBs ( Figure 3C ) and both L3mbtl2 À/À teratomas and EBs lack abundant differentiated elements ( Figures 3B, 3F , and 3G).
L3mbtl2 Physically Interacts with Factors Mediating Gene Repression and Pluripotency
To investigate the molecular basis of L3mbtl2's role in ES cells, we searched for proteins interacting with lentiviral vectorexpressed, FLAG-tagged L3mbtl2 in rescued knockout ES cells by mass spectrometry ( Figures 4A and 4B ). We identified peptides representative of 39 proteins involved in transcriptional regulation and chromatin organization (listed in Figure 4C) . Surprisingly, 23 of these ( Figure 4C , last column, Table S2 ) have previously been shown to interact with pluripotency factors or have been implicated in self-renewal and/or differentiation of pluripotent stem cells. The list included Oct4 and we could verify Marker genes for all germ layers were expressed in mutant and wild-type EBs, but gene expression was highly abnormal in the absence of L3mbtl2. Note that endodermal marker genes were significantly overexpressed at baseline and at later time points in L3mbtl2 À/À EBs. Trophectodermal markers were highly overexpressed in day 7 and day 12 in L3mbtl2 À/À EBs. On day 12, the expected decrease in Oct4, Nanog, Fgf5, and Brachyury expression was delayed in L3mbtl2 À/À EBs. Shown is mean relative mRNA expression (ratio of measured mRNA/ to GAPDH mRNA). Figures S4M-S4O ). In addition, areas of differentiation into skin (H, ectoderm), cartilage (I, mesoderm), and gut (J, endoderm) could be demonstrated but were very rare compared to wild-type teratomas.
(B-E) Significance was determined with two-tailed Student's t tests; means are from three independent samples; error bars represent SD. More histological analysis is shown in Figure S4 ; for synopsis of findings after knockout of other Polycomb group proteins see Table S1 .
this interaction by coimmunoprecipitation (CoIP) ( Figure 4D ), by reverse CoIP in rescued ES cells ( Figure 4G ), and by CoIP of the endogenous proteins in wild-type ES cells ( Figure 4H ). The interactions of L3mbtl2 with Oct4 and other pluripotency factors may explain its selective role in ES cells.
Our analysis also identified proteins that participate in several multiprotein complexes. These included ten constituents of the E2F6-complex (blue in Figure 4C ), known to interact with L3mbtl2 (Ogawa et al., 2002) . Three E2F6-complex components (Ring1a, Yaf2, and GLP) were not detected. We also detected Table S2 ). (D-F) Analysis of selected protein interactions by coimmunoprecipitation (IP) from nuclear extracts of L3mbtl2-F-rescued knockout ES cells followed by western blot (WB) analysis using antibodies against the indicated proteins. (D) L3mbtl2-F is associated with Oct4, but not Sox2 or Polycomb group proteins Bmi1, Suz12, or YY1. (E and F) Confirmation of L3mbtl2-F's association with components of the NuRD (E) and E2F6 complexes (F). (G) Reverse IP with antiserum against Ring1B, Mbd3, Hdac1, and Oct4 followed by western blot analysis with aFLAG (L3mbtl2-F); (G, right) interaction is not diminished in the presence of ethidium bromide (50 mg/ml). (H). Immunoprecipitation of candidate interactors followed by western blot with an antiserum against L3mbtl2 (top), and antisera directed at the immunoprecipitated proteins (bottom seven panels, IP controls). Note that endogenous L3mbtl2 interacts with Ring1B, E2F6, Oct4, and Hdac1. See Figure S5 for western blot analysis of expression levels of selected interactors.
all components of the NuRD-complex (red in Figure 4C ) and multiple Swi/Snf-complex components ( Figure 4C ). We confirmed the interaction of L3mbtl2-F with seven members of the NuRD-complex and five members of the E2F6-complex by CoIP (Figures 4D and 4E) . However, the CoIP with Mi2b, a central NuRD component, was weak ( Figure 4E ). The interactions with members of complexes do not necessarily implicate L3mbtl2 as part of these complexes as they may be indirect. Nevertheless, we showed that key interactions (Ring1b, Mbd3, Hdac1, and Oct4) are not the result of proximity at promoters, as they were stable in the presence of ethidium bromide, which disrupts DNA bridges ( Figure 4G ).
Candidate L3mbtl2 interactors also included Polycomb group proteins, specifically Ring1b, Rybp, Pcgf6, Rbbp4, and Rbbp7 ( Figure 4C ) (Simon and Kingston, 2009 ). Rbbp4 and Rbbp7, confirmed by CoIP ( Figure 4E ), were the only subunits of PRC2 detected by mass spectrometry ( Figure 4C ). Consistent with this, we failed to CoIP L3mbtl2 with Suz12 or Ezh2 (Figure 4H) . Moreover, analysis of L3mbtl2 À/À ES cells showed no differences in Ezh2 protein ( Figure S5A ) or global changes in H3K27me3 levels ( Figure S5B ). Thus, L3mbtl2 does not interact with PRC2. L3mbtl2 interacts with the E2F6-complex that harbors three proteins also linked to PRC1 (Ring1b, Pcgf6/Mblr, and Rybp, Figure 4C ). We confirmed the interaction with Rybp ( Figure 4F ) and Ring1b ( Figures 4F-4H) by CoIP. However, we did not detect peptides derived from Bmi1, known to associate with Ring1b at most PRC1 target genes in ES cells (Ku et al., 2008) . We also failed to detect an interaction of L3mbtl2 with Bmi1 by CoIP. Disruption of Ring1b in ES cells is associated with loss of protein expression of other PRC1 components, including Rybp and Bmi1 (see Table S1 ). However, the protein expression levels of Ring1b, Rybp, and Bmi1 were unchanged in L3mbtl2 À/À ES cells ( Figure S5A ) and so were the global levels of H2AK119ub1 ( Figure S5B ). Importantly, we detected Ring1b after IP with either E2F6 or Bmi1 ( Figure 4H , 6 th row). However, Bmi1 was only detectable after IP with Ring1b, but not E2F6 ( Figure 4H , bottom). These data suggest that two separate Ring1b-containing complexes coexist in ES cells, the canonical PRC1-complex that contains Bmi1 and the E2F6-complex that does not contain Bmi1. Only the latter interacts with L3mblt2 in ES cells.
Both Zinc Finger and MBT Domain Are Essential for the Function of L3mbtl2
To explore the molecular function of L3mbtl2's domains, we generated mutants and tested their potential to rescue selfrenewal and differentiation ( Figure 5 ). Deletion of each of L3mbtl2's four MBT domains ablated its ability to rescue the colony-growth defect ( Figure 5A ). In contrast, combined mutations of four highly conserved amino acid residues, critical for the binding of methylated histones (Guo et al., 2009) , had no effect on L3mbtl2's potential to rescue proliferation ( Figure 5B , bottom) or expression of SSEA1 ( Figure 5C , bottom). Remarkably however, deletions of the atypical C2C2 zinc finger domain ( Figure 5A ) and even point mutations of the zinc-coordinating residues abolished L3mbtl2's potential to rescue proliferation and differentiation ( Figures 5B and 5C ). This type of zinc finger, which is also found in Drosophila scm and polyhomeotic, is not thought to confer sequence-specific DNA binding (Wang et al., 2010) and may be involved in binding RNA. The proliferation defects in L3mbtl2 À/À ES cells were not rescued by any of the eight other MBT-protein family members ( Figure S6A ). Moreover, hybrid proteins with exchanged MBT domains and N-terminal portions of L3mbtl2 and Mbtd1 were inactive (Figure S6B) . We also determined the subcellular localization of mutant proteins lacking either the zinc finger or the MBT domains. Both types of mutants retained a predominantly nuclear localization similar to wild-type L3mbtl2, but were detected at markedly reduced levels (zinc finger) or were absent (MBT) in the chromatin-bound fraction ( Figure 5E ). Similarly, both the zinc finger domain and the MBT domains were required for efficient binding to Hdac1, G9A, and Ring1b ( Figure 5F ). Figure 6A , column 1 and 4). Conversely, expression was changed > 1.5-fold in the opposite direction upon (re-)expression of L3mbtl2-F in 69.5% of these genes (L3mbtl2-F vector infected cells compared with control vector infected cells; Figure 6A , column 2 and 3). Together, these criteria defined a set of 890 L3mbtl2-regulated genes (Table  S3) . 645 (72.5%) genes were upregulated in the absence of L3mbtl2 while only 245 genes (27.6%) were downregulated (Table S3 ). Of note, we confirmed the reversible pattern of gene expression in 10/10 regulated targets by quantitative PCR (not shown). Next, we investigated the genome-wide localization of L3mbtl2-F in L3mbtl2 À/À ES cells by ChIP-seq. L3mbtl2 was found to bind to 5,188 genomic sites that showed no signal in the control. Approximately 84% of these were located close to known genes and 36% in core promoters ( Figure 6B , Table  S4 ). Remarkably, > 60% of the L3mbtl2-bound genes are transcriptionally active. These findings contrast the binding pattern of the Polycomb protein Suz12 ( Figure 6C , Marson et al., 2008) , which is almost exclusively bound to bivalent genes. In agreement with our biochemical results (Figure 4) , a genome-wide comparison showed that significant proportions of L3mbtl2's binding sites are shared with Ring1b (32%, p < 10 À300 , GEO number: GSE#22680) and there is also overlap with Oct4 (10%, Marson et al., 2008) , and Mi2b (4%, Whyte et al., 2012) (data not shown). Only $5% of the L3mbtl2-bound targets were upregulated after L3mbtl2 loss ( Figure 6D ). This suggests redundancy in repression of L3mbtl2-bound genes and is roughly comparable with findings after loss of Ring1b and Eed, which results in upregulation of only 10%-13% or 18% of Polycomb-bound genes, respectively (Leeb et al., 2010; van der Stoop et al., 2008) .
To assess the overlap of gene occupancy by L3mbtl2, we defined a gene set of high-confidence, combined PRC1-and PRC2-bound genes (referred to as PRC1/2-bound, below). PRC1/2-bound genes were defined as binding PRC1 or PRC2 components in R 4 of 6 genome-wide analyses reported in two studies (Table S5 , Boyer et al., 2006; Ku et al., 2008) ; genes that bind Ring1b in the context of the E2F6-complex should not meet these criteria. Remarkably, $29% (266) of the
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L3mbtl2 Is Essential in ES Cells and Development PRC1/2-bound genes were also bound by L3mbtl2 ( Figure 6E , Table S3 ). However, only 3% (28) of the PRC1/2-bound genes were L3mbtl2-bound and were upregulated after L3mbtl2 loss ( Figure 6F , Table S3 ). Thus, L3mbtl2 binds a high proportion of PRC1/2 targets but is not required for repression of most of these genes. Conversely, most of the L3mbtl2-bound genes that were upregulated after L3mbtl2 loss were not PRC1/2-bound (139 / 83%) ( Figure 6F , Table S3 ). Moreover, none of the ten genes most highly upregulated (>10-fold) after L3mbtl2 loss was PRC1/2-bound (Table S3) . Thus, L3mbtl2 predominantly binds and regulates genes in ES cells that are not canonical, combined PRC1 and PRC2 targets.
Finally, we used the David classification tool to identify gene ontology categories associated with the 167 genes both bound and repressed by L3mbtl2. The analysis revealed strong associations with several categories consistent with the phenotype we observed, as well as with ''spermatogenesis'' ( Figure 6H ). Consistent with this, nine of the twelve most strikingly regulated genes (7.5-to 74-fold, Table S3 ) had roles in germ cells (Table S6) .
L3mbtl2 Generates and Maintains Repressive Chromatin Modifications at Its Target Genes by Recruiting a Repressive Multiprotein Complex
L3mbtl2 disruption in ES cells was not associated with global expression changes of its interactors Ring1b, Hdac1, and G9A ( Figure S5A) . Likewise, the chromatin modifications altered by these enzymes were not globally changed (i.e., H2AK119ub1, (E) Western blot analysis of L3mbtl2-F and deletion mutants of zinc finger, and MBT domains showed highly selective enrichment of L3mbtl2-F in nuclear and chromatin-bound extracts. Deletion of the zinc finger domain markedly reduced, and deletion of the MBT domains abolished, signal in chromatin-fraction but not the nuclear fraction. Lower panels show controls for the purity of the subcellular fractions.
(F) Disruption of the zinc-finger or MBT domains of L3mbtl2 prevent efficient coimmunoprecipitation with Hdac1 (top), G9A (second), and Ring1b (third panel) in nuclear extracts. Note that wild-type and mutant L3mbtl2 are expressed at similar levels (bottom). See Figure S6 for analysis of rescue potential of other MBT protein family members.
histone 3, and histone 4 acetylation [H3ac and H4ac], and H3K9 mono-and dimethylation [H3K9me1, me2; Figure S5] ). To investigate the local impact of L3mbtl2 on chromatin modifications at promoters, we probed a panel of target genes (Figure 7) , selected from genome-wide studies (Tables S3, S4 , and S5). Their differential expression and L3mbtl2-binding status were confirmed by RT-qPCR and ChIP-qPCR ( Figures 7A and 7B) . The panel included five L3mblt2-bound germ cell genes (Ddx4, Tex19, Piwil2, Stk31, Tcam1, orange dotted boxes, see Table  S6 ) and two regulated targets that do not bind L3mbtl2 (Stra8, Cidea) ( Figures 7A and 7B, left) . We also studied four combined PRC1/2 targets (blue dotted boxes), two of which are L3mbtl2-bound (Sox17, Foxa2; note: these genes bind lower, but significant levels of L3mbtl2) and three of which are L3mbtl2-repressed (Sox17, Foxa2, HoxB8) ( Figures 7A and 7B ). ChIP analysis of H3ac and H4ac revealed that histone acetylation at L3mbtl2-bound germ cell target promoters increased significantly after disruption of L3mbtl2 ( Figure 7C , top row), consistent with reduced local activity of a histone deacetylase, such as Hdac1 ( Figure 4E ). Moreover, H3K9me2 was detected Table S3 for 890 genes that were differentially expressed and rescued.
(B) A large proportion of genomic L3mbtl2-binding sites are localized at known core promoters. Genome-wide distribution of binding sites relative to annotated genes was determined by ChIP-seq. See Table S4 for details on 4,009 genes that bind close to genes (± 10,000 bp from transcriptional start site, TSS). (C) L3mbtl2 occupies active and bivalent genes. Top: shown are L3mbtl2 binding sites (black lines) at active genes (green), bivalent genes (yellow), and silent genes (red) (defined in Supplemental Experimental Procedures). Bottom: distribution of Suz12 is shown for comparison. Note that Suz12 almost exclusively binds to bivalent genes whereas L3mbtl2 also occupies active genes.
(D) L3mbtl2 is essential for repression of $5% of the genes it binds in ES cells. Venn diagram illustrating the overlap of genes bound by L3mbtl2 and genes upregulated in the absence of L3mbtl2 (L3mbtl2-repressed); see Tables S3 and S4 for detailed information.
(E) L3mbtl2 co-occupies a considerable minority of high confidence combined PRC1 and PRC2 target genes. Venn diagram illustrating the overlap of L3mbtl2-bound genes with a gene set of PRC1/2 target genes derived from published experiments; see Tables S5, S4 for details.
(F) Most genes that are both L3mbtl2-bound and repressed are not co-occupied by PRC1 and PRC2. Venn diagram; gene sets from Table S4 and S5. (G) Gene ontology categories associated with the 167 genes that were both bound and repressed by L3mbtl2. See Table S6 for information on L3mbtl2-regulated germ cell genes.
at all L3mbtl2-bound targets and was strongly diminished after L3mbtl2 loss ( Figure 7C , second row, right). H3K9me1 was diminished at some targets after L3mbtl2 loss ( Figure 7C , second row, left). These changes probably reflect decreased activity of G9A (Shinkai and Tachibana, 2011) . Notably, H3K9me3, a mark not dependent on G9A, was not significantly changed at any of the target genes ( Figure 7C , second row, right). As expected, we detected high levels of H3K27me3 (the mark of PRC2/Ezh2) and H2AK119ub1 (the mark of PRC1/ Ring1b) at combined PRC1/2 targets ( Figure 7C , bottom, blue boxes). In contrast, at germ cell genes, which are bound by L3mbtl2 but not PRC1/2, we detected only very low levels of both marks ( Figure 7C , bottom, orange boxes). Neither mark was appreciably affected by the absence of L3mbtl2 at combined PRC1/2 targets. However, at some germ cell gene promoters, the low level of H3K27me3 was significantly reduced after L3mbtl2 disruption ( Figure 7C , bottom, left). As these genes do not bind PRC2, the low level of H3K27me3 may be generated by G9A (Shinkai and Tachibana, 2011) . In contrast, the low levels of H2A119ub1 at germ cell genes were entirely unaffected by L3mbtl2 loss ( Figure 7C , bottom right). Next, we probed promoters for the presence of key components of chromatin modifying complexes. As expected, Bmi1, a hallmark of canonical PRC1 in ES cells (Ku et al., 2008) , and Suz12, an essential component of PRC2 (Boyer et al., 2006) , were strongly enriched at high-confidence PRC1/2 targets ( Figure 7D, top row) . These data correlate with high levels of H3K27me3 and H2AK119ub1 ( Figure 7C, bottom) . Enrichment was not diminished after disruption of L3mbtl2. Thus, L3mbtl2 is not required for the recruitment or activity of PRC1 or PRC2 at combined PRC1/2-bound targets, including those that bind L3mbtl2 (Sox17 and Foxa2). As expected, neither Bmi1 nor Suz12 was detected at L3mbtl2-bound germ cell genes, confirming the absence of canonical PRC1 and PRC2.
ChIP analysis of Ring1b showed enrichment of both PRC1/2 targets and germ cell genes ( Figure 7D , top row, right). However, enrichment was at least 10-fold lower at germ cell genes (p < 0.001). Disruption of L3mbtl2 did not reduce enrichment at high-confidence PRC1/2 targets, but significantly reduced enrichment at germ cell genes. Notably, however, Ring1b was not entirely lost at germ cell genes after L3mbtl2 disruption, but was merely reduced and sufficient to maintain H2AK119ub1 at normal levels ( Figure 7C, bottom, right) . These data demonstrate two different modes of binding of Ring1b to promoters in ES cells: high-level binding at PRC1/2 targets that is independent of L3mbtl2, and low-level binding at germ cell genes that is partially dependent on L3mbtl2.
G9A and Hdac1 were strongly enriched at all germ cell gene promoters ( Figure 7D , bottom row, orange boxes). For both, enrichment was strikingly reduced after L3mbtl2 loss. This correlated with increased histone acetylation and reduced H3K9me2 ( Figure 7C ). We did not detect enrichment for either enzyme at PRC1/2 targets, including Sox17 and FoxA2 ( Figure 7D , bottom row, blue boxes). As L3mbtl2 binds the latter two genes at comparatively at low levels ( Figure 7B) , it is possible that G9A and Hdac1 were present at these genes at low levels, not detected by our assay.
Our data show that L3mbtl2 loss at target genes results in reduction or loss of three enzymes (Ring1b, G9A, Hdac1) that have been linked to a protein complex associated with E2F6 in somatic cells. Consistent with this, ChIP analysis revealed that E2F6 bound to all five L3mbtl2-bound germ cell genes and its binding was reduced after L3mbtl2 disruption ( Figure 7D , bottom row, right). Thus, L3mbtl2 recruits a repressive complex to target genes in ES cells that bears strong resemblance with the previously described E2F6-complex (Ogawa et al., 2002) ( Figure 7E ).
DISCUSSION
Our study reveals essential roles for L3mbtl2 in early embryonic development and pluripotent stem cells. The consequences of L3mbtl2 loss include embryonic failure after implantation, compromised ES cell proliferation, failure to suppress differentiation gene expression in ES cells, and reduced competence for normal differentiation within EBs and teratomas. Our genomic studies revealed that L3mbtl2 loss in ES cells results in reversible gene expression changes of $900 genes. Thus, the complex phenotypes observed here may depend on the cooperation of multiple, possibly hundreds of, genes. Nevertheless, several (D) L3mbtl2 is not required for recruitment of PRC1 and PRC2, but recruits Ring1b, G9A, Hdac1, and E2F6. Top row: ChIP of Bmi1, Suz12, and Ring1b; note strong enrichment of Ring1b at canonical PRC1/2 targets and much weaker enrichment at germ cell targets (smallest difference: Ddx4 and Sox17 = 11.3-fold, p < 0.01); also note that enrichment after Ring1b ChIP was significantly reduced after L3mbtl2 loss at a several L3mbtl2-bound germ cell genes, but not at canonical PRC1/2 targets. Bottom row: ChIP of G9A, Hdac1, and E2F6. See also Figure S7 .
(A-D) Bar graphs represent the mean of 3 independent biological samples and SD. overexpression is known to block G 1 to S phase transition (Lee et al., 2010) , precisely as we observed it in L3mbtl2 À/À ES cells. Second, L3mbtl2 binds and represses Foxa2 and Sox17, which may contribute to the increased bias toward endoderm differentiation in L3mbtl2 À/À EBs. Third, L3mbtl2 binds and represses Lefty2 ( Figure S7A , Table S3 ), which inhibits gastrulation by antagonizing Nodal. In addition, overexpression of Cdx2, an indirect L3mbtl2 target, may explain the trophoectoderm bias we observed in L3mbtl2 À/À EBs and teratomas (Niwa et al., 2005) . Aspects of the phenotype after L3mbtl2 loss resemble findings after disruption of other Polycomb group proteins. For example, embryos lacking Ezh2, Eed, Suz12, and Ring1b exhibit gastrulation failure (Simon and Kingston, 2009) (Table S1 ). Likewise, increased expression of endoderm genes (Figure 3 ) has been observed in ES cells lacking Ring1b, Eed, and Suz12 (Table  S1 ). Moreover, like L3mbtl2 À/À ES cells, Ring1b À/À ES cells fail to repress trophectoderm genes (Table S1 ). Finally, like L3mbtl2 À/À EBs (Figure 3 ), EBs lacking Eed, Ezh2, and Jarid2 fail to extinguish primitive populations expressing Oct4, Fgf5, or Brachyury (Table S1 ). Despite these similarities, none of the phenotypes associated with loss of Polycomb group proteins phenocopy our findings (Table S1 ). Perhaps the most unique feature is L3mbtl2's strong impact on proliferation. Among the Polycomb group proteins, only Eed is associated with an appreciable (but less severe) ES cell growth defect upon gene disruption (Leeb et al., 2010) (Table S1 ). Our proteomic analysis revealed that L3mbtl2 interacts with known constituents of multiprotein complexes, including the NuRD (Whyte et al., 2012) and E2F6 complexes (Ogawa et al., 2002) as well as with some components of the Polycomb complexes PRC1 (Ring1b, Rybp, Pcgf6) and PRC2 (Rbbp4, Rbbp7) (Simon and Kingston, 2009) . We focused our analysis on deciphering the relationship of L3mbtl2 with other Polycomb complexes.
We demonstrate that L3mbtl2 functions independently of PRC2 in ES cells. L3mbtl2 is not necessary for recruitment or maintenance of PRC2. The majority of PRC2 target genes do not bind L3mbtl2, and L3mbtl2 loss does not diminish H3K27me3 or Suz12 binding at genes bound by both L3mbtl2 and PRC2. Moreover, L3mbtl2 binding is insufficient for recruitment of PRC2, as most genes bound and regulated by L3mbtl2 are not bound by PRC2. In agreement with this, L3mbtl2 did not biochemically interact with PRC2 core components. Despite their independence, L3mbtl2 and PRC2 cooperate in the repression of some genes. For example, Sox17 and Foxa2 are upregulated not only after L3mbtl2 loss, but also after loss of the PRC2 component Eed (Leeb et al., 2010) .
Very recently, PRC1 in human somatic cells has been resolved into six distinct groups of complexes (PRC1.1-1.6) with mutually exclusive ring finger components (PCGF1-6), distinct associated proteins, and genomic localization (Gao et al., 2012) . PRC1.2 and 1.4 (containing MEL18/PCGF2 and BMI1/PCGF4, respectively) are most similar to the canonical PRC1 that occupies combined PRC1/2 targets (Boyer et al., 2006; Ku et al., 2008) , while L3mbtl2 is associated with PRC1.6 (containing MBLR/PCGF6) (Gao et al., 2012) . The notion that ''PRC1'' represents multiple entities dovetails with our findings. First, both Bmi1 (PRC1.4) and L3mbtl2 (PRC1.6) interacted with Ring1b, but not with each other. Second, L3mbtl2 (PRC1.6) binds only a minority of combined PRC1/2 target genes (PRC1.2, 1.4). Third, loss of L3mbtl2 (PRC1.6) at target genes that are also combined PRC1/2 targets (PRC1.2, 1.4) did not decrease binding of Bmi1, Ring1b, or H2AK119ub1. Finally, in contrast to canonical PRC1 (PRC1.2, 1.4), the majority of L3mbtl2-bound and -repressed genes do not bind PRC2. Together, these data show that L3mbtl2 is neither a component of ''canonical'' PRC1 in ES cells nor required for its stability or enzymatic activity.
Instead, L3mbtl2 is a constituent of a PRC1-family complex in ES cells that has been previously designated E2F6 complex, PRC1L4, or PRC1.6 in somatic cells and was detected in mass spectrometry experiments with E2F6, RING1B, SMCX, and L3MBTL2 (Gao et al., 2012; Ogawa et al., 2002; Sá nchez et al., 2007; Tahiliani et al., 2007; Trojer et al., 2011) . A biological function of this complex has not been demonstrated. Our data strongly suggest that this PRC1-family complex is tightly linked to the essential requirement for L3mbtl2 in ES cells. We demonstrate that L3mbtl2 is required for optimal recruitment of at least four likely components of this complex to selected germ cell genes ( Figure 7E) . Moreover, these genes bear the marks of the three associated enzymes, H3K9me2 (G9a), low H3ac, H4ac (Hdac1), and H2AK119ub1 (Ring1b). Notably, we detected the latter mark and Ring1b at 10-fold lower levels than that at canonical PRC1 targets. Disruption of L3mbtl2 resulted in markedly increased H3ac and H4ac as well as reduced H3K9me2, but, in contrast to data in somatic cells (Trojer et al., 2011) , did not affect H2AK119ub1. Since L3mblt2 loss at promoters is associated with increased target gene expression without changing H2AK119ub1 levels, this mark alone is insufficient to maintain repression. However, Ring1b and/or H2AK119ub1 are probably necessary for optimal L3mbtl2-mediated repression because the germ cell genes regulated by L3mbtl2 in ES cells were shown to be at least partially derepressed in Ring1b À/À ES cells (Leeb et al., 2010 and Table S6 ).
Notably, the importance of G9A and Hdac1 in ES cells and early development has also been demonstrated by gene targeting (Dovey et al., 2010; Shinkai and Tachibana, 2011) . In addition to histone modification, chromatin compaction by Ring1b (Simon and Kingston, 2009 ) and L3mbtl2 itself (Trojer et al., 2011) probably contribute to a repressive chromatin structure. Together, our data suggest that L3mbtl2 organizes repressive chromatin at critical targets in ES cells by supporting the assembly and maintenance of an evolved PRC1-family complex that utilizes mechanisms not classically linked with Polycomb proteins ( Figure 7E ). Like L3mbtl2, Ring1b and Rybp are essential for development (Table S1) , and both are constituents of all types of PRC1-complexes (Gao et al., 2012) . In contrast, disruption of Bmi1/PCGF4 and Mel18/PCGF2 was not embryonic lethal even in combination (Akasaka et al., 2001) . Intriguingly, therefore, the L3mbtl2-associated complex may be the only PRC1-family complex that is essential for early development. L3mbtl2 is a homolog of Drosophila sfmbt (Guo et al., 2009 ), which binds the DNA-binding transcription factor pho, a recruiter of Drosophila polycomb complexes to specific genomic sites (Klymenko et al., 2006) . L3mbtl2 does not bind to YY1, the mammalian homolog of pho (Figure 4 ), but it interacts with E2F6, Mga/Max (binding both E-box motifs and T-box motifs; Ogawa et al., 2002) , and Oct4 (Figure 4) . However, we did not find a dominant role of these factors in recruitment of L3mbtl2. Oct4 co-occupies 10% of L3mbtl2-bound genomic sites, and conversely, L3mbtl2 is present at only 2% of Oct4 binding sites, so the two factors are primarily recruited independently (see Figures S7A-S7C) . We did detect a weak, significant association between genomic L3mblt2 binding sites and E-box motifs (p < 10 À6 ), which might be bound by Mga/Max, but no significant association L3mbtl2-binding with the E2F motif. This was surprising because of the strong biochemical interaction and colocalization of E2F6 and L3mbtl2 in somatic cells (Trojer et al., 2011) and in ES cells (Figure 7D and S7F) . Providing an explanation, we found that E2F6-binding is dependent on L3mbtl2 at most (but not all, Figure S7 ) genes, so E2F6 does not always depend on its DNA-binding site for localization. Moreover, E2F6 À/À mice are viable (Storre et al., 2005) , so E2F6 is dispensable for the essential role L3mbtl2-dependent repressive complexes in early development. Intriguingly, four germ cell genes that are bound by E2F6 and upregulated after E2F6 loss in MEFs (Pohlers et al., 2005; Storre et al., 2005) were not upregulated in L3mbtl2 À/À ES cells ( Figure S7G ), and the germ cell genes regulated by L3mbtl2 in ES cells were not upregulated in L3mbtl2 À/À MEFs ( Figure S7H ). Therefore, the importance of different constituents of the complex varies with different cellular contexts and target genes. The function of L3mbtl2 appears highly selective for pluripotent cells and early embryonic cells. Despite expression, we detected no obvious roles in MEFs ( Figure S3 ), in the maintenance of hematopoiesis, or in CNS development (after Mx-Cre or Nestin-Cre deletion, respectively). The striking overlap between L3mbtl2's interaction partners and the ES cell core transcriptional network provides leads for understanding the molecular basis of its selective role in ES cells.
The function of the major domains of L3mbtl2 remains poorly understood. In our structure/function analysis, the wellcharacterized methylated histone-binding cavity in the fourth MBT domain was irrelevant for its functions ( Figure 5) . A similar conclusion was recently drawn from testing mutants in a transcriptional assay (Trojer et al., 2011) and, additionally, it was shown that L3mbtl2 is able to bind unmethylated histones. We demonstrated that both the zinc finger and the MBT domains are absolutely required for its function. Future work is needed to identify the precise ligands of L3mbtl2's domains and decipher the molecular basis for its interactions. As mutations in L3mbtl2 have been found in brain tumors (Northcott et al., 2009 ), it will be interesting to investigate whether, like PRC2 (Hock, 2012) , L3mbtl2-dependent complexes play important roles beyond development in adult tissues and cancer.
EXPERIMENTAL PROCEDURES Gene Expression Analysis
Northern blot analysis of tissues and RT-PCR from ES-cells and embryoid bodies and microarray analysis were performed as described in Supplemental Experimental Procedures.
Gene Targeting of L3mbtl2
Generation of the targeting vector, ES cell culture, mutant ES cells, and mice as well as analysis of embryos are described in Supplemental Experimental Procedures. All animal studies were performed in accordance with the guidelines and under the supervision of the Massachusetts General Hospital Subcommittee on Animal Research (SRAC).
Analysis of ES Cells
Colony-size assay, growth curve generation, immunocytochemistry, flow cytometry, apoptosis assay, and cell cycle analysis are described in the Supplemental Experimental Procedures.
Embryoid Body Differentiation and Teratoma Formation
The differentiation potential of ES cells was assessed by gene expression analysis after embryoid body formation using the hanging drop method and by histology and immunohistology after teratoma formation following subcutaneous injection in vivo. Details are described in the Supplemental Experimental Procedures.
Generation of Expression Vectors, Mutagenesis, and Rescue Assays
Full-length MBT domain protein coding sequences were PCR-amplified from commercially available clones or reverse-transcribed ES cell RNA introducing C-terminal FLAG tags in the 3-terminal primers. Mutagenesis was performed in pBluescript, followed by sequencing of the entire coding region and transfer into a lentiviral expression vector to perform rescue assays. Details are described in the Supplemental Experimental Procedures.
Analysis of Protein Interactions
Protein purification, mass spectrometry analysis, coimmunoprecipitation, and western blot analysis are described in the Supplemental Experimental Procedures.
Chromatin Immunoprecipitation Assays
Preparation of whole-cell lysate, immunoprecipitaton, amplification of DNA templates, and ChIP-seq are described in the Supplemental Experimental Procedures.
ACCESSION NUMBERS
The microarray data for mutant ES cells have been deposited in the NCBI GEO repository with accession number GSE38801.
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